✨
AI Summary
- Onchilles Pharma discusses their neutrophil-derived pan-cancer therapy.
- The ELANE pathway offers broad cancer cell killing and immune training.
- N17350, based on neutrophil elastase, is being developed.
Guests on This Episode
CT
Court Turner
2 podcast appearances
LB
Lev Becker
2 podcast appearances